@ARTICLE{
author={Jacob Saiju|,Howard James F Jr|,Bril Vera|,Peric Stojan Z|0000-0002-2979-556X,De Bleecker Jan L|,T'joen Caroline|,Travers Jackalyne|,Utsugisawa Kimiaki|,Verschuuren Jan|,Mantegazza Renato|},
year={2022},
title={Long-Term Assessment of Efgartigimod in Patients with Generalised Myasthenia Gravis: Adapt Plus Study Interim Results},
journal={JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY},
volume={93},
number={9},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Howard James F Jr|,Bril Vera|,Tuan Vu|,Karam Chafic|,Peric Stojan Z|0000-0002-2979-556X,De Bleecker Jan L|,Murai Hiroyuki|,Pasnoor Mamatha|,Sacca Francesco|,Meisel Andreas|,Guglietta Antonio|,T'joen Caroline|,Utsugisawa Kimiaki|,Verschuuren Jan|,Mantegazza Renato|},
year={2022},
title={Efficacy, Safety, and Tolerability of Efgartigimod in Acetylcholine Receptor Autoantibody Seronegative Patients with Generalized Myasthenia Gravis: Integrated Interim Analysis of the Adapt and Adapt plus Studies},
journal={MUSCLE & NERVE},
volume={65},
number={},
pages={S13-S14},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Howard James F Jr|,Bril Vera|,Tuan Vu|,Karam Chafic|,Peric Stojan Z|0000-0002-2979-556X,De Bleecker Jan L|,Murai Hiroyuki|,Meisel Andreas|,Beydoun Said|,Pasnoor Mamatha|,Guglietta Antonio|,T'joen Caroline|,Utsugisawa Kimiaki|,Verschuuren Jan|,Mantegazza Renato|},
year={2022},
title={Long-Term Safety, Tolerability, and Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Interim Results of the Adapt plus Study},
journal={MUSCLE & NERVE},
volume={65},
number={},
pages={S9-S10},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Howard James|,Bril Vera|,Vu Tuan|,Karam Chafic|,Peric Stojan Z|0000-0002-2979-556X,Murai Hiroyuki|,Guglietta Antonio|,Ulrichts Peter|,Vangeneugden Tony|,Utsugisawa Kimiaki|,Verschuuren Jan JGM|,Mantegazza Renato|},
year={2021},
title={Efficacy, Safety, and Tolerability of Efgartigimod in Patients With Generalized Myasthenia Gravis: Analysis of the Phase 3 ADAPT Study},
journal={NEUROLOGY},
volume={96},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Mantegazza Renato|,...|,Peric Stojan Z|0000-0002-2979-556X,...|,(broj koautora 16)|},
year={2021},
title={Safety and tolerability of efgartigimod in patients with generalized myasthenia gravis: Phase 3 adapt study results},
journal={JOURNAL OF THE NEUROLOGICAL SCIENCES},
volume={429},
number={},
pages={-},
document_type={Meeting Abstract},
} 

